IT services provider DXC Technology (NYSE:DXC) reported calendar Q3 2026 (fiscal Q2 2027) results topping the market’s revenue expectations, but sales fell by 4% year on year to $3.03 billion.
Is now the time to buy DXC? Find out in our full research report (it’s free for active Edge members).
DXC (DXC) Q3 CY2026 highlights:
- Revenue $3.03 billion vs S&P analysts’ estimates of $3.00 billion (4% year-on-year decline, 1.3% beat)
- Adjusted EPS $0.67 vs S&P analysts’ estimates of $0.55 (22% beat)
- Revenue guidance The company dropped its revenue guidance for the full year to $11.95 billion at the midpoint from $12.23 billion, a 2.3% decrease
- Adjusted EPS guidance Management lowered its full-year adjusted EPS guidance to $2.38 at the midpoint, a 10.4% decrease
- Operating margin 1.8%, down from 5.1% in the same quarter last year
- Organic revenue fell 4% year on year (beat)
- Market capitalization $2.43 billion
StockStory’s take
DXC Technology’s third quarter results were met with a sharply negative market reaction, as the company reported a year-over-year revenue decline and a significant drop in operating margin. Management cited ongoing challenges in converting pipeline opportunities, particularly in the Americas and the UK and Ireland, as a primary factor limiting sales growth. CEO Raul Fernandez acknowledged that the competitive environment has intensified, with traditional project-based deals delayed and customers taking longer to make decisions. He noted, “We are not satisfied with our current performance,” openly addressing the company’s sales execution and the need for better alignment between supply and demand.
Looking forward, DXC’s updated guidance reflects a cautious stance, with management lowering both revenue and non-GAAP EPS expectations for the remainder of the year. The company is prioritizing improvements in sales execution and continued investment in agentic and AI-driven solutions, but faces uncertainty around the timing of large deal closures. Fernandez outlined that “the priority now is execution, improving the core, scaling what works, and creating sustainable long-term value,” while CFO Rob Del Bene highlighted ongoing cost reduction efforts to support margins amid reduced revenue expectations. Management remains focused on expanding its AI-certified engineering talent and commercializing new offerings, but recognizes that broader market and customer budget dynamics may weigh on near-term growth.
Key insights from management’s remarks
Management attributed the quarter’s results to ongoing pipeline conversion challenges and delays in large project deals, while highlighting progress in AI-based solutions and organizational changes.
-
Pipeline conversion headwinds: DXC experienced slower conversion of its sales pipeline, especially for large deals in the UK public sector and smaller project-based work in the Americas financial services and retail verticals. Del Bene noted that these delays were due to both customer indecision and increased competition, resulting in a lower bookings performance.
-
Sales execution and organizational changes: Fernandez emphasized the recent addition of Paul Taylor as President, whose focus is on streamlining global operations and improving sales execution. Management acknowledged that some deal conversion issues stemmed from internal friction and lack of accountability in go-to-market processes.
-
AI and agentic solutions momentum: The company highlighted strong traction in its AI-powered offerings, such as OASIS and GrowthX, which have begun to see commercial adoption. DXC secured a core banking modernization win with a global bank and saw a sixfold increase in OASIS utilization from last quarter, driven by new AI-native workplace services and expanded agentic workflows.
-
Insurance platform growth: DXC’s SaaS-based Assure Platform continued to build momentum, with more than 275 enterprise insurance customers and the first sales of AI-enabled Smart Apps. The Smart Apps pipeline grew over 20% sequentially, contributing to the insurance segment’s outperformance relative to the rest of the business.
-
Cybersecurity and trust focus: The launch of DXC Frontier Code Assurance—a managed service leveraging AI for software vulnerability detection and remediation—was positioned as a key differentiator. Fernandez stressed the importance of operational context and safety in AI deployments, especially for regulated industries, and noted that DXC engineers are certified across multiple leading AI platforms.
Drivers of future performance
Management expects ongoing sales execution improvements, AI commercialization, and cost control to shape DXC’s near-term outlook, despite continued deal timing risks.
-
Sales pipeline conversion risk: Del Bene indicated that lower conversion rates from the pipeline are expected to persist, with management not counting on a near-term rebound in large deal closures. The company is focusing on closing the gap by chasing more qualified opportunities and simplifying customer engagement.
-
AI and agentic offerings expansion: Fernandez highlighted continued investment in AI engineering talent and the commercialization of new agentic solutions as a source of future revenue growth. Management believes that rapid adoption of offerings like OASIS and DXC Frontier Code Assurance could unlock follow-on deals and larger projects, though the timing remains uncertain.
-
Cost actions and margin management: To offset revenue decline, DXC is accelerating cost takeout initiatives and reevaluating its expense base for next year. Del Bene confirmed that cost reductions are being deepened to protect margins without undermining strategic investments in AI and cloud services.
Catalysts in upcoming quarters
In the coming quarters, the StockStory team will watch (1) whether DXC’s core sales execution improves, resulting in stronger pipeline conversion rates and large deal wins, (2) the pace of adoption and revenue contribution from agentic and AI-based solutions, and (3) the continued growth and stickiness of the insurance SaaS platform. Additionally, we will monitor the impact of cost reduction initiatives on margins and any strategic actions affecting the company’s portfolio.
DXC currently trades at $14.22, down from $15.19 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Now could be the perfect time to invest in these stocks
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.